Grand Opening
Symposium
Stay Informed
For more information, contact:Carol A. Corigliano
Business Development Assoc.
Phone: 716.881.8906
Email: cc253@buffalo.edu
Speakers Bios
Larry Goldstein, Ph.D.
Dr.
Goldstein is Professor of Cellular and Molecular Medicine at the University
of California, San Diego, School of Medicine. He is also an Investigator
with the Howard Hughes Medical Institute. He receives grant funding from
the NIH, the Johns Hopkins ALS Center, ALSA, and the High Q Foundation.
Dr. Goldstein received his B.A. degree in biology and genetics from UCSD in 1976 and his Ph.D. in genetics from the University of Washington, Seattle in 1980. He did postdoctoral research at the University of Colorado at Boulder from 1980-1983 and the Massachusetts Institute of Technology from 1983-1984. He was Assistant, Associate, and Full Professor at Harvard University in the Department of Cellular and Developmental Biology from 1984-1993 and moved to UCSD and HHMI in 1993.
His awards include a Senior Scholar Award from the Ellison Medical Foundation, an American Cancer Society Faculty Research Award, and the Loeb Chair in Natural Sciences when he was at Harvard University.
Dr. Goldstein's research is focused on understanding the molecular mechanisms of movement inside neurons and the role of transport failures in neurodegenerative diseases. His lab has recently discovered important links between these transport processes and diseases such as Alzheimer's Disease and Huntington's Disease. Dr. Goldstein has also had an active role in National Science policy.
He has served on many public science advisory committees, has written about, spoken about, and been interviewed on numerous occasions on science issues by print and broadcast media, and has testified on a number of occasions in the U.S. House of Representatives and the Senate about NIH funding and stem cell research. Dr. Goldstein also served as co-chair of the scientific advisory committee to the campaign for the Proposition 71 stem cell research initiative, which authorizes $3 billion in tax-free state bonds to fund stem cell research in California over the next 10 years. As a co-founder and consultant of the biotechnology company Cytokinetics he has also had an active role in private industry.
